Pivotal, randomized U.S. study of the Symbiot™ covered stent system in patients with saphenous vein graft disease: Eight-month angiographic and clinical results from the Symbiot III trial

Catheterization and Cardiovascular Interventions

Volumn 68, Issue 3, 2006, Pages 379-388

  Turco, Mark A ^a   Buchbinder, Maurice ^b   Popma, Jeffrey J ^c   Weissman, Neil J ^d   Mann, Tift ^e   Doucet, Serge ^f   Johnson Jr , Warren L ^g   Greenberg, Joel D ^h   Leadley, Katrin ⁱ   Russell, Mary E ⁱ  

^a WASHINGTON ADVENTIST HOSPITAL   (United States)

^b SCRIPPS MEMORIAL HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d WASHINGTON HOSPITAL CENTER   (United States)

^e WAKEMED HEALTH AND HOSPITALS   (United States)

^f MONTREAL HEART INSTITUTE   (Canada)

^g SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^h FLORIDA HOSPITAL   (United States)

ⁱ BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

Polytetrafluoroethylene; Restenosis; Saphenous vein grafts; Stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; POLITEF; TICLOPIDINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; ARTERY DIAMETER; ARTICLE; CELL MIGRATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMBOLISM; EVALUATION; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; SAPHENOUS VEIN GRAFT; STATISTICAL SIGNIFICANCE; STENT; UNITED STATES; VEIN GRAFT DISEASE;

ADULT; AGED; BLOOD VESSEL PROSTHESIS IMPLANTATION; CANADA; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; ENDPOINT DETERMINATION; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; POLYTETRAFLUOROETHYLENE; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SAPHENOUS VEIN; STENTS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; UNITED STATES;

EID: 33748333147     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.20873     Document Type: Article

References (24)

1. Baim DS. Percutaneous treatment of saphenous vein graft disease: The ongoing challenge. J Am Coll Cardiol 2003;42:1370-1372.
2. Peykar S, Angiolillo DJ, Bass TA, Costa MA. Saphenous vein graft disease. Minerva Cardioangiol 2004;52:379-390.
3. Weintraub WS, Jones EL, Morris DC, King SB III, Guyton RA, Craver JM. Outeome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery. Circulation 1997;95:868-877.
4. de Feyter PJ, van Suylen RJ, de Jaegere PP, Topol EJ, Serruys PW. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J Am Coll Cardiol 1993;21:1539-1549.
5. Savage MP, Douglas JS, Fischman DL, Pepine CJ, King SB, Werner JA, Bailey SR, Overlie PA, Fenton SH, Brinker JA, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 1997;337:740-747.
6. Wong SC, Baim DS, Schatz RA, Teirstein PS, King SB III, Curry RC Jr, Heuser RR, Ellis SG, Cleman MW, Overlie P, et al. Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: The multicenter US Palmaz-Schatz stem experience. J Am Coll Cardiol 1995;26:704-712.
7. de Jaegere PP, van Domburg RT, de Feyter PJ, Ruygrok PN, van der Giessen WJ, van den Brand MJ, Serruys PW. Long-term clinical outcome after stem implantation in saphenous vein grafts. J Am Coll Cardiol 1996;28:89-96.
8. Frimerman A, Rechavia E, Eigler N, Payton MR, Makkar R, Litvack F. Long-term follow-up of a high risk cohort after stent implantation in saphenous vein grafts. J Am Coll Cardiol 1997;30:1277-1283.
9. Keeley EC, Velez CA, O'Neill WW, Safian RD. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol 2001;38:659-665.
10. Lau GT, Lowe HC, Kritharides L. Cardiac saphenous vein bypass graft disease. Semin Vasc Med 2004;4:153-159.
11. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, Kaya U, Popma JJ, Ho KK, Kuntz RE. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002;105:1285-1290.
12. Popma JJ, Cox N, Hauptmann KE, Reifart N, Virmani R, Emira K, Murphy S, Gibson CM, Grube E. Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention. Catheter Cardiovasc Interv 2002;57:125-134.
13. Stone GW, Rogers C, Hermiller J, Feldman R, Hall P, Haber R, Masud A, Cambier P, Caputo RP, Turco M, et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 2003;108:548-553.
14. Elsner M, Auch-Schwelk W, Britten M, Walter DH, Schachinger V, Zeiher AM. Coronary stent grafts covered by a polytetrafluoroethylene membrane. Am J Cardiol 1999;84:335-338.
15. Baldus S, Koster R, Elsner M, Walter DH, Arnold R, Auch-Schwelk W, Berger J, Rau M, Meinertz T, Zeiher AM, et al. Treatment of Aortocoronary vein graft lesions with membrane-covered stents: A multicenter surveillance trial. Circulation 2000;102:2024-2027.
16. Baldus S, Koster R, Reimers J, Kahler J, Meinertz T, Hamm CW. Membrane-covered stents: A new treatment strategy for saphenous vein graft lesions. Catheter Cardiovasc Interv 2001;53:1-4.
17. Gercken U, Lansky AJ, Buellesfeld L, Desai K, Badereldin M, Mueller R, Selbach G, Leon MB, Grube E. Results of the Jostent coronary stent graft implantation in various clinical settings: Procedural and follow-up results. Catheter Cardiovasc Interv 2002;56:353-360.
18. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 1990;82:1193-1202.
19. Mehran R, Mintz GS, Satler LF, Pichard AD, Kent KM, Bucher TA, Popma JJ, Leon MB. Treatment of in-stent restenosis with excimer laser coronary angioplasty: Mechanisms and results compared with PTCA alone. Circulation 1997;96:2183-2189.
20. van der Zwet PM, Reiber JH. A new approach for the quantification of complex lesion morphology: The gradient field transform; basic principles and validation results. J Am Coll Cardiol 1994;24:216-224.
21. Stankovic G, Colombo A, Presbitero P, van den Branden F, Inglese L, Cernigliaro C, Niccoli L, Bartorelli AL, Rubartelli P, Reifart N, et al. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: The Randomized evaluation of polytetrafluoroethylene covered stent in Saphenous vein grafts (RECOVERS) trial. Circulation 2003;108:37-42.
22. Schachinger V, Hamm CW, Munzel T, Haude M, Baldus S, Grube E, Bonzel T, Konorza T, Koster R, Arnold R, et al. A randomized trial of polytetrafluoroethylene-membrane-covered stems compared with conventional stents in aortocoronary saphenous vein grafts. J Am Coll Cardiol 2003;42:1360-1369.
23. Laarman GJ, Kiemeneij F, Mueller R, Guagliumi G, Cobaugh M, Patrick W. Serruys, on behalf of the Symbiot II trial investigators. Feasibility, safety, and preliminary efficacy of a novel ePTFE-covered self-expanding stent in saphenous vein graft lesions: The Symbiot II trial. Catheter Cardiovasc Interv 2005;64:361-368.
24. Blackman DJ, Choudhury RP, Banning AP, Channon KM. Failure of the Symbiot PTFE-covered stent to reduce distal embolization during percutaneous coronary intervention in saphenous vein grafts. J Invasive Cardiol 2005;17:609-612.